DWM
BSX icon

Dakota Wealth Management’s Boston Scientific BSX Stock Holding History

Dakota Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65M Buy
155,926
+148,221
+1,924% +$8.05M 0.13% 155
2026
Q1 		$483K Sell
7,705
-115,539
-94% -$9.24M 0.01% 552
2025
Q4 		$11.8M Buy
123,244
+642
+0.5% +$62.9K 0.21% 93
2025
Q3 		$12M Sell
122,602
-116,064
-49% -$12M 0.24% 81
2025
Q2 		$25.6M Buy
238,666
+5,701
+2% +$577K 0.54% 41
2025
Q1 		$23.5M Buy
232,965
+164,946
+242% +$16.6M 0.55% 37
2024
Q4 		$6.08M Buy
68,019
+10,224
+18% +$900K 0.14% 133
2024
Q3 		$4.84M Buy
57,795
+7,455
+15% +$588K 0.11% 164
2024
Q2 		$3.88M Buy
50,340
+6,244
+14% +$457K 0.09% 194
2024
Q1 		$3.02M Buy
44,096
+16,308
+59% +$1.05M 0.08% 216
2023
Q4 		$1.61M Buy
+27,788
New +$1.48M 0.06% 244

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dakota Wealth Management's BSX Position: Q2 2026 in Review

Dakota Wealth Management increased its Boston Scientific (BSX) stake by 1,924% in Q2 2026, buying an estimated $8.05M and bringing the position to 155,926 shares worth $6.65M. The position accounts for 0.13% of the portfolio, ranked #155.

Dakota Wealth Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.6M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Dakota Wealth Management held 155,926 shares of Boston Scientific worth $6.65M as of Q2 2026.
  • Dakota Wealth Management bought 148,221 Boston Scientific shares in Q2 2026, an estimated $8.05M.
  • Boston Scientific made up 0.13% of Dakota Wealth Management's portfolio in Q2 2026, its #155 holding.
  • Dakota Wealth Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Dakota Wealth Management's Boston Scientific position peaked at $25.6M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.